Management Of Low And Favorable-Intermediate Risk Prostate Cancer

Dr. Brian Lawenda discusses the main management options (as recommended by the National Comprehensive Cancer Network) for patients with low-risk and favorable intermediate-risk prostate cancer. For more detail on these options (as well as pelvic MRI,  genomic tumor testing, hereditary cancer genetic testing), see the other video lessons on these topics.